Hepatic damage exacerbates cisplatin-induced acute kidney injury in Sprague-Dawley rats

References

• Acésio, N. O., G. S. Carrijo, T. H. Batista, J. L. Damasceno, M. B. Côrrea, M. G. Tozatti, W. R. Cunha, and D. C. Tavares. 2017. Assessment of the antioxidant, cytotoxic, and genotoxic potential of the Annona muricata leaves and their influence on genomic stability. Journal Toxicogical Environment Health A 80:1290–300.
   PubMed Web of Science ®Google Scholar
• Attia, K. A., A. T. N’dri Yoman, A. K. Mahassadi, K. C. Ackoundou-N’guessan, H. Y. Kissi, and Y. F. Bathaix. 2008. Impact of renal failure on survival of African patients with cirrhosis. Saudi Journal Kidney Diseases Transplant 19:587–92.
   PubMedGoogle Scholar
• Belcher, J. M. 2015. Acute kidney injury in liver disease: Role of biomarkers. Advancement Chronic Kidney Diseases 22:368–75.
   PubMed Web of Science ®Google Scholar
• Betrosian, A. P., B. Agarwal, and E. E. Douzinas. 2007. Acute renal dysfunction in liver diseases. World Journal of Gastroenterology : WJG 13:5552–59.
   PubMed Web of Science ®Google Scholar
• Carvalho Rodrigues, M. A., G. Gobe, N. A. Santos, and A. C. Santos. 2012. Carvedilol protects against apoptotic cell death induced by cisplatin in renal tubular epithelial cells. Journal Toxicogical Environment Health A 75:981–90.
   PubMed Web of Science ®Google Scholar
• Cheon, J. H., S. Y. Kim, J. Y. Son, Y. P. Kang, J. H. An, J. H. Kwon, H. S. Song, A. Moon, B. M. Lee, and H. S. Kim. 2016. Pyruvate kinase M2: A novel biomarker for the early detection of acute kidney injury. Toxicogical Researcher 32:47–56.
   PubMed Web of Science ®Google Scholar
• Cristofori, P., E. Zanetti, D. Fregona, A. Piaia, and A. Trevisan. 2007. Renal proximal tubule segment-specific nephrotoxicity: An overview on biomarkers and histopathology. Toxicogical Pathologists 35:270–75.
   PubMed Web of Science ®Google Scholar
• Davenport, A., M. F. Sheikh, E. Lamb, B. Agarwal, and R. Jalan. 2017. Acute kidney injury in acute-on-chronic liver failure: Where does hepatorenal syndrome fit? Kidney International 92:1058–70.
   PubMed Web of Science ®Google Scholar
• Egerod Israelsen, M., L. L. Gluud, and A. Krag. 2015. Acute kidney injury and hepatorenal syndrome in cirrhosis. Journal of Gastroenterology and Hepatology 30:236–43.
   PubMed Web of Science ®Google Scholar
• Fujii, Y., R. Segawa, M. Kimura, L. Wang, Y. Ishii, R. Yamamoto, R. Morita, K. Mitsumori, and M. Shibutani. 2013. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats. Chemico-Biological Interactions 205:108–18.
   PubMed Web of Science ®Google Scholar
• George, B., M. S. Joy, and L. M. Aleksunes. 2018. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Experimental Medicine and Biology 243:272–82. doi:10.1177/1535370217745302.
   PubMed Web of Science ®Google Scholar
• Ginès, P., and R. W. Schrier. 2009. Renal failure in cirrhosis. The New England Journal of Medicine 361:1279–90.
   PubMed Web of Science ®Google Scholar
• Karvellas, C. J., F. Durand, and M. K. Nadim. 2015. Acute kidney injury in cirrhosis. Critical Care Clinical 31:737–50.
   PubMed Web of Science ®Google Scholar
• Kaushal, G. P., V. Kaushal, X. Hong, and S. V. Shah. 2001. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney International 60:1726–36.
   PubMed Web of Science ®Google Scholar
• Kim, K. S., H. Y. Yang, H. Song, Y. R. Kang, J. Kwon, J. An, J. Y. Son, S. J. Kwack, Y. M. Kim, O. N. Bae, M. Y. Ahn, J. Lee, S. Yoon, B. M. Lee, and H. S. Kim. 2017. Identification of a sensitive urinary biomarker, selenium-binding protein 1, for early detection of acute kidney injury. Journal Toxicogical Environment Health A 80:453–64.
   PubMed Web of Science ®Google Scholar
• Kim, N. H., S. Lee, M. J. Kang, H. G. Jeong, W. Kang, and T. C. Jeong. 2014. Protective effects of diallyl sulfide against thioacetamide-induced toxicity: A possible role of cytochrome P450 2E1. Biomolecular Therapeutics 22:149–54.
   PubMed Web of Science ®Google Scholar
• Koen, Y. M., D. Sarma, H. Hajovsky, N. A. Galeva, T. D. Williams, J. L. Staudinger, and R. P. Hanzlik. 2013. Protein targets of thioacetamide metabolites in rat hepatocytes. Chemical Research in Toxicology 26:564–74.
   PubMed Web of Science ®Google Scholar
• Lee, E. K., Y. J. Shin, E. Y. Park, N. D. Kim, A. Moon, S. J. Kwack, J. Y. Son, S. Kacew, B. M. Lee, O. N. Bae, and H. S. Kim. 2017. Selenium-binding protein 1: A sensitive urinary biomarker to detect heavy metal-induced nephrotoxicity. Archives of Toxicology 91:1635–48.
   PubMed Web of Science ®Google Scholar
• Miller, R. P., R. K. Tadagavadi, G. Ramesh, and W. B. Reeves. 2010. Mechanisms of cisplatin nephrotoxicity. Toxins 2:2490–518.
   PubMed Web of Science ®Google Scholar
• Nikolić-Kokić, A., A. Mijušković, N. Tatalović, J. Nestorov, M. Miler, Z. Oreščanin-Dušić, M. Nikolić, V. Milošević, D. Blagojević, M. Spasić, and Č. Miljević. 2016. Effects of antipsychotic drug administration on antioxidative defense enzymes in male rat kidney. Journal Toxicogical Environment Health A 79:905–11.
   PubMed Web of Science ®Google Scholar
• Pabla, N., and Z. Dong. 2008. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney International 73:994–1007.
   PubMed Web of Science ®Google Scholar
• Porter, W. R., and R. A. Neal. 1978. Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. Drug Metabolism and Disposition: the Biological Fate of Chemicals 6:379–88.
   PubMed Web of Science ®Google Scholar
• Rewa, O., and S. M. Bagshaw. 2014. Acute kidney injury-epidemiology, outcomes and economics. Natural Reviews Nephrology 10:193–207.
   PubMed Web of Science ®Google Scholar
• Rognant, N. 2015. Acute kidney injury in patients with chronic liver disease. World Journal Hepatology 7:993–1000.
   PubMed Web of Science ®Google Scholar
• Serpeloni, J. M., B. L. Batista, J. P. Angeli, G. R. Barcelos, L. Bianchi Mde, F. Barbosa, Jr, and L. M. Antunes. 2013. Antigenotoxic properties of chlorophyll b against cisplatin-induced DNA damage and its relationship with distribution of platinum and magnesium in vivo. Journal Toxicogical Environment Health A 76:345–53.
   PubMed Web of Science ®Google Scholar
• Sharp, C. N., and L. J. Siskind. 2017. Developing better mouse models to study cisplatin-induced kidney injury. American Journal of Physiology. Renal Physiology 313:F835–F841.
   PubMed Web of Science ®Google Scholar
• Shinke, H., S. Masuda, Y. Togashi, Y. Ikemi, A. Ozawa, T. Sato, Y. H. Kim, M. Mishima, T. Ichimura, J. V. Bonventre, and K. Matsubara. 2015. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer Chemotherapy and Pharmacology 76:989–96.
   PubMed Web of Science ®Google Scholar
• Sin, E. I., C. S. Chia, G. H. C. Tan, K. C. Soo, and M. C. Teo. 2017. Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. International Journal Hyperthermia 33 (6):690–95.
   PubMed Web of Science ®Google Scholar
• Tujios, S. R., L. S. Hynan, M. A. Vazquez, A. M. Larson, E. Seremba, C. M. Sanders, and W. M. Lee. 2015. Acute Liver Failure Study Group. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association 13:352–59.
   PubMed Web of Science ®Google Scholar
• Wallace, M. C., K. Hamesch, M. Lunova, Y. Kim, R. Weiskirchen, P. Strnad, and S. L. Friedman. 2015. Standard operating procedures in experimental liver research: Thioacetamide model in mice and rats. Laboratory Animals 49:21–29.
   PubMed Web of Science ®Google Scholar
• Won, A. J., S. Kim, Y. G. Kim, K. B. Kim, W. S. Choi, S. Kacew, K. S. Kim, J. H. Jung, B. M. Lee, S. Kim, and H. S. Kim. 2016. Discovery of urinary metabolomic biomarkers for early detection of acute kidney injury. Molecular Biosystematics 12:133–44.
   PubMed Web of Science ®Google Scholar
• Wong, F. 2015a. The evolving concept of acute kidney injury in patients with cirrhosis. Natural Reviews Gastroenterology Hepatology 12:711–19.
   PubMed Web of Science ®Google Scholar
• Wong, F. 2015b. Definition and diagnosis of acute kidney injury in cirrhosis. Digest Diseases 33:539–47.
   PubMed Web of Science ®Google Scholar
• Wong, F. 2016. Acute kidney injury in liver cirrhosis: New definition and application. Clinical Molecular Hepatology 22:415–22.
   PubMed Web of Science ®Google Scholar
• Yuan, W., Y. Y. Zhang, Z. G. Zhang, Y. Zou, H. Z. Lu, and Z. P. Qian. 2017. Risk factors and outcomes of acute kidney injury in patients with hepatitis B virus-related acute-on-chronic liver failure. The American Journal of the Medical Sciences 353:452–58.
   PubMed Web of Science ®Google Scholar
• Zimmerman, H. J. 1978. Drug-induced liver disease. Drugs 16:25–45.
   PubMed Web of Science ®Google Scholar